Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (294)	9/1/2009 11:53:06 AM
From: BulbaMan	Read Replies (2) \| Respond to of 418

Mid-week update: I did the MEDX reallocation using a $16 buyout price and the 8/28 closing prices. Hope that's Ok with folks. Today's ACAD blow-up badly hurt a bunch of portfolios, knocking GENE's portfolio out of first place. Peace & good health, Bulba

To: BulbaMan who wrote (294)	9/4/2009 6:02:53 PM
From: BulbaMan	1 Recommendation Read Replies (1) \| Respond to of 418

9/4/09 update You just can't keep those Bulls down! Although they looked exhausted early in the week, by week's end they appeared fully recovered.. At Friday's close, the Nasdaq Composite Index was up 28.45% CYTD, or Contest Year To Date, (vs. up 29.09% CYTD a week ago) and the Nasdaq Biotech Index was up 14.20% CYTD (vs. up 13.55% CYTD a week ago). Due in large part to ACAD's blow-up the Contest median did not fare as well, closing up 20.95% CYTD (vs. up 25.75% CYTD a week ago). ACAD's collapse also had a major impact on the Contest rankings. GENE's portfolio was cut almost in half and RKRW's portfolio now leads by a wide margin, while NIGEL's portfolio has moved into third place. As a result of two buyouts, NIGEL's portfolio is now fairly concentrated with only 7 stocks and a big move by any of them could turn it into a contender for the top spot. The week's closing CYTD percentages are: RKRW up 137.58%, GENE up 81.44%, NIGEL up 77.78%. At Friday's close, 26 of the 32 Contest portfolios were in the black and 20 of the 32 were beating the NBI. Portfolio adjustments: As indicated in my mid-week update, I did the MEDX buyout reallocation using a $16 buyout price and the 8/28 closing prices. There have been more buyouts than usual this year, increasing the odds that I've screwed up the reallocations. So, please let me know if my performance numbers are way different from yours. Have a terrific Labor Day weekend folks! Below is the Top Ten list on 9/4/09: 9/4/09 Rank Name Profit/Loss 1 RKRW 137,580 2 GENE 81,435 3 NIGEL 77,776 4 MIKE 65,843 5 BULBA 61,368 6 ASHLEY 61,138 7 ENZYME 59,304 8 GEORGIA 57,239 9 BIOFISH 49,594 10 SCARAM 48,094 (All corrections, especially adjustments for splits, greatly appreciated.)